Enhancement of Rituximab-induced cell death by the physical association of CD20 with CD40 molecules on the cell surface.
about
Drug-Free Macromolecular Therapeutics--A New Paradigm in Polymeric NanomedicinesThe preclinical discovery of rituximab for the treatment of non-Hodgkin's lymphoma.Therapeutic antibodies against cancer stem cells: a promising approach.Technetium-99m- or Cy7-Labeled Rituximab as an Imaging Agent for Non-Hodgkin Lymphoma.CD20-targeting in B-cell malignancies: novel prospects for antibodies and combination therapies.A small, portable RNA device for the control of exon skipping in mammalian cells.
P2860
Enhancement of Rituximab-induced cell death by the physical association of CD20 with CD40 molecules on the cell surface.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Enhancement of Rituximab-induc ...... molecules on the cell surface.
@en
type
label
Enhancement of Rituximab-induc ...... molecules on the cell surface.
@en
prefLabel
Enhancement of Rituximab-induc ...... molecules on the cell surface.
@en
P2093
P2860
P356
P1476
Enhancement of Rituximab-induc ...... molecules on the cell surface
@en
P2093
Amal Nadiri
Anna Colavecchio
Ghada S Hassan
Loubna Al-Zoobi
Malek Jundi
Suzanne Salti
Walid Mourad
P2860
P304
P356
10.1093/INTIMM/DXU046
P577
2014-05-15T00:00:00Z